APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neutropenia Biologic Drug Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neutropenia Biologic Drug Treatment Industry Growth and Trends Forecast to 2032

31 December 2025101 pages

Choose your research edition.

Industry ResearchNeutropenia Biologic Drug Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Neutropenia Biologic Drug Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Neutropenia Biologic Drug Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neutropenia Biologic Drug Treatment Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Neutropenia Biologic Drug Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

According to APO Research, the global Neutropenia Biologic Drug Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neutropenia Biologic Drug Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neutropenia Biologic Drug Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neutropenia Biologic Drug Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Neutropenia Biologic Drug Treatment market include Kyowa Kirin, Teva Pharmaceutical Industries Ltd., Sanofi, Novartis, Pfizer, Baxter International, Amgen, Partner Therapeutics and Myelo Therapeutics GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neutropenia Biologic Drug Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neutropenia Biologic Drug Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neutropenia Biologic Drug Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neutropenia Biologic Drug Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Neutropenia Biologic Drug Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neutropenia Biologic Drug Treatment Market by Company

Kyowa Kirin

Teva Pharmaceutical Industries Ltd.

Sanofi

Novartis

Pfizer

Baxter International

Amgen

Partner Therapeutics

Myelo Therapeutics GmbH

Enzychem Lifesciences Corporation

Dong-A ST Co.,Ltd.

CVS Health

Cellerant Therapeutics

Neutropenia Biologic Drug Treatment Segment by Type

Filgrastim

Lenograstim

Pegfilgrastim

Sargramostim

Lipegfilgrastim

Neutropenia Biologic Drug Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Neutropenia Biologic Drug Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neutropenia Biologic Drug Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neutropenia Biologic Drug Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neutropenia Biologic Drug Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Neutropenia Biologic Drug Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Neutropenia Biologic Drug Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Neutropenia Biologic Drug Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Neutropenia Biologic Drug Treatment Market Share by Region (2021-2026) Table 4. Global Neutropenia Biologic Drug Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Neutropenia Biologic Drug Treatment Market Share by Region (2027-2032) Table 6. Global Neutropenia Biologic Drug Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Neutropenia Biologic Drug Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Neutropenia Biologic Drug Treatment Market Size Share by Type (2021-2026) Table 9. Global Neutropenia Biologic Drug Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Neutropenia Biologic Drug Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Neutropenia Biologic Drug Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Neutropenia Biologic Drug Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Neutropenia Biologic Drug Treatment Market Size Share by Application (2021-2026) Table 24. Global Neutropenia Biologic Drug Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Neutropenia Biologic Drug Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Neutropenia Biologic Drug Treatment Industry Trends Table 37. Neutropenia Biologic Drug Treatment Industry Drivers Table 38. Neutropenia Biologic Drug Treatment Industry Opportunities and Challenges Table 39. Neutropenia Biologic Drug Treatment Industry Restraints Table 40. Global Neutropenia Biologic Drug Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Neutropenia Biologic Drug Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Neutropenia Biologic Drug Treatment Key Company Headquarters & Area Served Table 44. Global Neutropenia Biologic Drug Treatment Company, Product Type & Application Table 45. Global Neutropenia Biologic Drug Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Neutropenia Biologic Drug Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Kyowa Kirin Company Information Table 49. Kyowa Kirin Business Overview Table 50. Kyowa Kirin Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Kyowa Kirin Neutropenia Biologic Drug Treatment Product Portfolio Table 52. Kyowa Kirin Recent Development Table 53. Teva Pharmaceutical Industries Ltd. Company Information Table 54. Teva Pharmaceutical Industries Ltd. Business Overview Table 55. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Product Portfolio Table 57. Teva Pharmaceutical Industries Ltd. Recent Development Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sanofi Neutropenia Biologic Drug Treatment Product Portfolio Table 62. Sanofi Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Novartis Neutropenia Biologic Drug Treatment Product Portfolio Table 67. Novartis Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pfizer Neutropenia Biologic Drug Treatment Product Portfolio Table 72. Pfizer Recent Development Table 73. Baxter International Company Information Table 74. Baxter International Business Overview Table 75. Baxter International Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Baxter International Neutropenia Biologic Drug Treatment Product Portfolio Table 77. Baxter International Recent Development Table 78. Amgen Company Information Table 79. Amgen Business Overview Table 80. Amgen Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Amgen Neutropenia Biologic Drug Treatment Product Portfolio Table 82. Amgen Recent Development Table 83. Partner Therapeutics Company Information Table 84. Partner Therapeutics Business Overview Table 85. Partner Therapeutics Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Partner Therapeutics Neutropenia Biologic Drug Treatment Product Portfolio Table 87. Partner Therapeutics Recent Development Table 88. Myelo Therapeutics GmbH Company Information Table 89. Myelo Therapeutics GmbH Business Overview Table 90. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product Portfolio Table 92. Myelo Therapeutics GmbH Recent Development Table 93. Enzychem Lifesciences Corporation Company Information Table 94. Enzychem Lifesciences Corporation Business Overview Table 95. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Portfolio Table 97. Enzychem Lifesciences Corporation Recent Development Table 98. Dong-A ST Co.,Ltd. Company Information Table 99. Dong-A ST Co.,Ltd. Business Overview Table 100. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Product Portfolio Table 102. Dong-A ST Co.,Ltd. Recent Development Table 103. CVS Health Company Information Table 104. CVS Health Business Overview Table 105. CVS Health Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. CVS Health Neutropenia Biologic Drug Treatment Product Portfolio Table 107. CVS Health Recent Development Table 108. Cellerant Therapeutics Company Information Table 109. Cellerant Therapeutics Business Overview Table 110. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Portfolio Table 112. Cellerant Therapeutics Recent Development Table 113. North America Neutropenia Biologic Drug Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Neutropenia Biologic Drug Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Neutropenia Biologic Drug Treatment Market Share by Country (2021-2026) Table 116. North America Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Neutropenia Biologic Drug Treatment Market Share Forecast by Country (2027-2032) Table 118. Europe Neutropenia Biologic Drug Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Neutropenia Biologic Drug Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Neutropenia Biologic Drug Treatment Market Share by Country (2021-2026) Table 121. Europe Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Neutropenia Biologic Drug Treatment Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Neutropenia Biologic Drug Treatment Market Share by Country (2021-2026) Table 126. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Neutropenia Biologic Drug Treatment Market Share Forecast by Country (2027-2032) Table 128. Latin America Neutropenia Biologic Drug Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Neutropenia Biologic Drug Treatment Market Share by Country (2021-2026) Table 131. Latin America Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Neutropenia Biologic Drug Treatment Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Neutropenia Biologic Drug Treatment Market Share by Country (2021-2026) Table 136. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Neutropenia Biologic Drug Treatment Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Neutropenia Biologic Drug Treatment Product Image Figure 3. Global Neutropenia Biologic Drug Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Neutropenia Biologic Drug Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Neutropenia Biologic Drug Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Neutropenia Biologic Drug Treatment Market Share by Region (2021-2032) Figure 7. North America Neutropenia Biologic Drug Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Neutropenia Biologic Drug Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Neutropenia Biologic Drug Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Filgrastim Image Figure 13. Global Filgrastim Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Lenograstim Image Figure 15. Global Lenograstim Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Pegfilgrastim Image Figure 17. Global Pegfilgrastim Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Sargramostim Image Figure 19. Global Sargramostim Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Lipegfilgrastim Image Figure 21. Global Lipegfilgrastim Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Neutropenia Biologic Drug Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Neutropenia Biologic Drug Treatment Market Share by Type 2025 VS 2032 Figure 24. North America Neutropenia Biologic Drug Treatment Market Size Share by Type (2021-2032) Figure 25. Europe Neutropenia Biologic Drug Treatment Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Share by Type (2021-2032) Figure 27. Latin America Neutropenia Biologic Drug Treatment Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Neutropenia Biologic Drug Treatment Market Size Share by Type (2021-2032) Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Online Pharmacies Image Figure 32. Global Online Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Retail Pharmacies Image Figure 34. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Neutropenia Biologic Drug Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Neutropenia Biologic Drug Treatment Market Share by Application 2025 VS 2032 Figure 37. North America Neutropenia Biologic Drug Treatment Market Size Share by Application (2021-2032) Figure 38. Europe Neutropenia Biologic Drug Treatment Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Share by Application (2021-2032) Figure 40. Latin America Neutropenia Biologic Drug Treatment Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Neutropenia Biologic Drug Treatment Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Neutropenia Biologic Drug Treatment Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Neutropenia Biologic Drug Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Neutropenia Biologic Drug Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Neutropenia Biologic Drug Treatment Market Share by Country (2021-2032) Figure 47. Europe Neutropenia Biologic Drug Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Neutropenia Biologic Drug Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Neutropenia Biologic Drug Treatment Market Share by Country (2021-2032) Figure 50. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Neutropenia Biologic Drug Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Neutropenia Biologic Drug Treatment Market Share by Country (2021-2032) Figure 53. Latin America Neutropenia Biologic Drug Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Neutropenia Biologic Drug Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Neutropenia Biologic Drug Treatment Market Share by Country (2021-2032) Figure 56. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Neutropenia Biologic Drug Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Neutropenia Biologic Drug Treatment Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Filgrastim
  • Lenograstim
  • Pegfilgrastim
  • Sargramostim
  • Lipegfilgrastim
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Kyowa Kirin
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Novartis
  • Pfizer
  • Baxter International
  • Amgen
  • Partner Therapeutics
  • Myelo Therapeutics GmbH
  • Enzychem Lifesciences Corporation
  • Dong-A ST Co.,Ltd.
  • CVS Health
  • Cellerant Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Neutropenia Biologic Drug Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Neutropenia Biologic Drug Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Neutropenia Biologic Drug Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Neutropenia Biologic Drug Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Neutropenia Biologic Drug Treatment Market Size (2021-2032)
  8. 1.5.1 North America Neutropenia Biologic Drug Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Neutropenia Biologic Drug Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Neutropenia Biologic Drug Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Growth Rate (2021-2032)
2 Neutropenia Biologic Drug Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Filgrastim
  3. 2.1.2 Lenograstim
  4. 2.1.3 Pegfilgrastim
  5. 2.1.4 Sargramostim
  6. 2.1.5 Lipegfilgrastim
  7. 2.2 Global Neutropenia Biologic Drug Treatment Market Size by Type
  8. 2.2.1 Global Neutropenia Biologic Drug Treatment Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Neutropenia Biologic Drug Treatment Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Neutropenia Biologic Drug Treatment Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Neutropenia Biologic Drug Treatment Market Size by Regions
  12. 2.3.1 North America Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Neutropenia Biologic Drug Treatment Market Size Breakdown by Type (2021-2026)
3 Neutropenia Biologic Drug Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacies
  3. 3.1.2 Online Pharmacies
  4. 3.1.3 Retail Pharmacies
  5. 3.2 Global Neutropenia Biologic Drug Treatment Market Size by Application
  6. 3.2.1 Global Neutropenia Biologic Drug Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Neutropenia Biologic Drug Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Neutropenia Biologic Drug Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Neutropenia Biologic Drug Treatment Market Size by Regions
  10. 3.3.1 North America Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Neutropenia Biologic Drug Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Neutropenia Biologic Drug Treatment Industry Trends
  2. 4.2 Neutropenia Biologic Drug Treatment Industry Drivers
  3. 4.3 Neutropenia Biologic Drug Treatment Industry Opportunities and Challenges
  4. 4.4 Neutropenia Biologic Drug Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Neutropenia Biologic Drug Treatment Revenue (2021-2026)
  2. 5.2 Global Neutropenia Biologic Drug Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Neutropenia Biologic Drug Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Neutropenia Biologic Drug Treatment Company, Product Type & Application
  5. 5.5 Global Neutropenia Biologic Drug Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Neutropenia Biologic Drug Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Neutropenia Biologic Drug Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Neutropenia Biologic Drug Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Kyowa Kirin
  2. 6.1.1 Kyowa Kirin Company Information
  3. 6.1.2 Kyowa Kirin Business Overview
  4. 6.1.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Kyowa Kirin Neutropenia Biologic Drug Treatment Product Portfolio
  6. 6.1.5 Kyowa Kirin Recent Developments
  7. 6.2 Teva Pharmaceutical Industries Ltd.
  8. 6.2.1 Teva Pharmaceutical Industries Ltd. Company Information
  9. 6.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
  10. 6.2.3 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Product Portfolio
  12. 6.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Neutropenia Biologic Drug Treatment Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Neutropenia Biologic Drug Treatment Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Neutropenia Biologic Drug Treatment Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Baxter International
  32. 6.6.1 Baxter International Company Information
  33. 6.6.2 Baxter International Business Overview
  34. 6.6.3 Baxter International Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Baxter International Neutropenia Biologic Drug Treatment Product Portfolio
  36. 6.6.5 Baxter International Recent Developments
  37. 6.7 Amgen
  38. 6.7.1 Amgen Company Information
  39. 6.7.2 Amgen Business Overview
  40. 6.7.3 Amgen Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Amgen Neutropenia Biologic Drug Treatment Product Portfolio
  42. 6.7.5 Amgen Recent Developments
  43. 6.8 Partner Therapeutics
  44. 6.8.1 Partner Therapeutics Company Information
  45. 6.8.2 Partner Therapeutics Business Overview
  46. 6.8.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Partner Therapeutics Neutropenia Biologic Drug Treatment Product Portfolio
  48. 6.8.5 Partner Therapeutics Recent Developments
  49. 6.9 Myelo Therapeutics GmbH
  50. 6.9.1 Myelo Therapeutics GmbH Company Information
  51. 6.9.2 Myelo Therapeutics GmbH Business Overview
  52. 6.9.3 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product Portfolio
  54. 6.9.5 Myelo Therapeutics GmbH Recent Developments
  55. 6.10 Enzychem Lifesciences Corporation
  56. 6.10.1 Enzychem Lifesciences Corporation Company Information
  57. 6.10.2 Enzychem Lifesciences Corporation Business Overview
  58. 6.10.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Portfolio
  60. 6.10.5 Enzychem Lifesciences Corporation Recent Developments
  61. 6.11 Dong-A ST Co.,Ltd.
  62. 6.11.1 Dong-A ST Co.,Ltd. Company Information
  63. 6.11.2 Dong-A ST Co.,Ltd. Business Overview
  64. 6.11.3 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Product Portfolio
  66. 6.11.5 Dong-A ST Co.,Ltd. Recent Developments
  67. 6.12 CVS Health
  68. 6.12.1 CVS Health Company Information
  69. 6.12.2 CVS Health Business Overview
  70. 6.12.3 CVS Health Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 CVS Health Neutropenia Biologic Drug Treatment Product Portfolio
  72. 6.12.5 CVS Health Recent Developments
  73. 6.13 Cellerant Therapeutics
  74. 6.13.1 Cellerant Therapeutics Company Information
  75. 6.13.2 Cellerant Therapeutics Business Overview
  76. 6.13.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Portfolio
  78. 6.13.5 Cellerant Therapeutics Recent Developments
7 North America
  1. 7.1 North America Neutropenia Biologic Drug Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Neutropenia Biologic Drug Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Neutropenia Biologic Drug Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Neutropenia Biologic Drug Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Neutropenia Biologic Drug Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Neutropenia Biologic Drug Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst